AstraZeneca's Revolutionary Blood Pressure Pill Shows Promise
A groundbreaking new hypertension drug, Baxdrostat, developed by AstraZeneca, has demonstrated remarkable success in clinical trials, potentially offering new hope for millions with treatment-resistant high blood pressure in the UK.